Carsten Thiel was born in berlin and remained in the then- divided Germany through his youth. This is where he excelled in his studies and eventually ended up studying chemistry in Malbrook. Carsten Thiel had a huge desire to gain some insight into the Anglo Saxon education system. He ended up leaving his home country in order to attend the University of Bristol in the UK. That is where he studied organic chemistry and after he received his Bachelor of Science degree, he decided to specialize in biochemistry.
After completing his education, Carsten Thiel had found a fascination with the ever changing world of pharmaceuticals. This came from an exciting position with Hoffman la-Roche which was a ground breaking biotechnology firm.
He started initially as the communications and product manager for the company and Thiel was able to show off his previous education with the newly learned experience and quickly gained a very positive reputation with the company. Later he was offered some increased responsibility in the area of market assessment and scientific marketing.
People ask him how a normal day looks for him and he says that after spending his morning breakfast with his family, the work day can become hectic. It is easy to become over taken by your calendar and end up having too many outstanding commitments that can take you away from certain portions of the “job”. View Related Info Here.
Things like this can and will create a long term effect and build your company a legacy so Thiel states that he tries to prioritize his time in a way that not only accomplishes daily operational tasks, but also focuses on long- term changes as well. Currently Carsten Thiel says that he finds himself continuously in awe of the ways that technology is able to be used to help patients of all kinds.
An article with Pharmafile entiled “EUSA Pharma Bolsters Senior Leadership Team With Two Appointments”, Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two newly-created roles: Dr Carsten Thiel as President Europe and Dr Darrel P Cohen as Head of Clinical Development